EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From Parallel Programming to Bidirectional Crosstalk: The Brain–Kidney Axis in Cardiovascular–Kidney–Metabolic Syndrome

Chien-Ning Hsu iD, You-Lin Tain iD

Antioxidants · 19.06.2026 · 15 (6) · 769

DOI: 10.3390/antiox15060769 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 19.06.2026. Verfasst von Chien-Ning Hsu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung 801, Taiwan. Die Arbeit nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, National Science and Technology Council, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular–kidney–metabolic (CKM) syndrome is a systemic, interdependent disorder arising from the convergence of metabolic dysfunction, chronic kidney disease, and cardiovascular pathology. Anchored in the Developmental Origins of Health and Disease (DOHaD) framework, this review advances a “parallel hit” model, primarily based on evidence from experimental animal studies, particularly rodent models, posited that early-life environmental insults concurrently program structural and functional vulnerabilities in both renal and central nervous system hubs. These early perturbations prime susceptibility long before clinical manifestations emerge. CKM progression is conceptualized as a two-stage trajectory, with an initial phase of parallel programming affecting kidney and brain development, followed by a transition to maladaptive bidirectional crosstalk. In the later phase, heightened efferent sympathetic outflow and aberrant afferent renal signaling—potentiated by uremic toxin accumulation, neuroinflammation, and blood–brain barrier disruption—drive a self-perpetuating cycle that accelerates cardiorenal and metabolic injury. Key integrative mechanisms, including oxidative stress, chronic low-grade inflammation, mitochondrial dysfunction, and gut microbiota dysbiosis, serve as convergent pathways linking early-life exposures to adult CKM phenotypes. These pathways not only sustain disease progression but also represent actionable therapeutic targets. Importantly, this framework underscores the translational potential of early-life “reprogramming” strategies. Interventions such as precision nutrition, antioxidant supplementation, microbiota-directed therapies (including prebiotics, probiotics, and postbiotics), and mechanism-based pharmacotherapies may mitigate or reverse maladaptive programming. However, much of the current mechanistic evidence remains preclinical, and further human studies are needed to validate these pathways and therapeutic approaches. Collectively, this dual-hub paradigm reframes CKM syndrome as a life-course continuum rather than a late-stage comorbidity cluster, emphasizing the necessity of early, mechanism-driven interventions to stabilize the brain–kidney axis and improve long-term cardiovascular–kidney–metabolic outcomes.

Schlagwörter

Stichwörter der Autor:innen

Developmental Origins of Health and Disease (DOHaD)brain–kidney axiscardiovascular diseasecardiovascular–kidney–metabolic syndromechronic kidney diseasegut microbiotaoxidative stress

Autor:innen und Institutionen

  • Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung 801, Taiwan.
  • Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
  • School of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
  • Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
  • College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
  • Doctoral Program of Clinical and Experimental Medicine, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.

ORCID-Profile: Chien-Ning Hsu, You-Lin Tain

Förderung

  • National Science and Technology Council
  • National Science and Technology Council, Taiwan

Zitieren

APA

Hsu, C. N., & Tain, Y. L. (2026). From Parallel Programming to Bidirectional Crosstalk: The Brain–Kidney Axis in Cardiovascular–Kidney–Metabolic Syndrome. Antioxidants, 15(6), 769. https://doi.org/10.3390/antiox15060769

Vancouver

Hsu CN, Tain YL. From Parallel Programming to Bidirectional Crosstalk: The Brain–Kidney Axis in Cardiovascular–Kidney–Metabolic Syndrome. Antioxidants. 2026;15(6):769. doi:10.3390/antiox15060769

BibTeX
@article{Hsu2026,
  author = {Hsu, Chien-Ning and Tain, You-Lin},
  title = {From Parallel Programming to Bidirectional Crosstalk: The Brain–Kidney Axis in Cardiovascular–Kidney–Metabolic Syndrome},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {6},
  pages = {769},
  doi = {10.3390/antiox15060769}
}
Kostenlos starten →